China State FDA Urges Manufacturers To Abandon Some Projects Ahead Of GMP Implementation - DIA China Conference
This article was originally published in PharmAsia News
Executive Summary
BEIJING - China's new good manufacturing practices guidelines for pharmaceuticals officially came into effect March 1, and China's State FDA is now trying to educate domestic companies on how they can implement the new standards. One bit of advice being offered is: "Give up.
You may also be interested in...
EU Proposed Regulation Raises Concerns From China’s API Exporters
EU draft guidance calls for greater clarity on the source of API, putting many Chinese manufacturers in a tough position.
China's State FDA Imposes New Regulatory Requirements On CMOs And Third-party Contracts
SHANGHAI - In a bid to prevent the export of counterfeit medicines, China is tightening its supervision of contract manufacturing organizations doing work for overseas drug makers. To that end, China's State FDA recently issued a notice on new rules governing cross-border contract manufacturing
China's State FDA Imposes New Regulatory Requirements On CMOs And Third-party Contracts
SHANGHAI - In a bid to prevent the export of counterfeit medicines, China is tightening its supervision of contract manufacturing organizations doing work for overseas drug makers. To that end, China's State FDA recently issued a notice on new rules governing cross-border contract manufacturing